Study protocol subacromial impingement syndrome: the identification of pathophysiologic mechanisms (SISTIM)

<p>Abstract</p> <p>Background</p> <p>The Subacromial Impingement Syndrome (SIS) is the most common diagnosed disorder of the shoulder in primary health care, but its aetiology is unclear. Conservative treatment regimes focus at reduction of subacromial inflammatory reactions or pathologic scapulohumeral motion patterns (<it>intrinsic </it>aetiology). Long-lasting symptoms are often treated with surgery, which is focused at enlarging the subacromial space by resection of the anterior part of the acromion (based on <it>extrinsic </it>aetiology). Despite that acromionplasty is in the top-10 of orthopaedic surgical procedures, there is no consensus on its indications and reported results are variable (successful in 48-90%). We hypothesize that the aetiology of SIS, i.e. an increase in subacromial pressure or decrease of subacromial space, is multi-factorial. SIS can be the consequence of pathologic scapulohumeral motion patterns leading to humerus cranialisation, anatomical variations of the scapula and the humerus (e.g. hooked acromion), a subacromial inflammatory reaction (e.g. due to overuse or micro-trauma), or adjoining pathology (e.g. osteoarthritis in the acromion-clavicular-joint with subacromial osteophytes).</p> <p>We believe patients should be treated according to their predominant etiological mechanism(s). Therefore, the objective of our study is to identify and discriminate etiological mechanisms occurring in SIS patients, in order to develop tailored diagnostic and therapeutic strategies.</p> <p>Methods</p> <p>In this cross-sectional descriptive study, applied clinical and experimental methods to identify intrinsic and extrinsic etiologic mechanisms comprise: MRI-arthrography (eligibility criteria, cuff status, 3D-segmented bony contours); 3D-motion tracking (scapulohumeral rhythm, arm range of motion, dynamic subacromial volume assessment by combining the 3D bony contours and 3D-kinematics); EMG (adductor co-activation) and dynamometry instrumented shoulder radiographs during arm tasks (force and muscle activation controlled acromiohumeral translation assessments); Clinical phenotyping (Constant Score, DASH, WORC, and SF-36 scores).</p> <p>Discussion</p> <p>By relating anatomic properties, kinematics and muscle dynamics to subacromial volume, we expect to identify one or more predominant pathophysiological mechanisms in every SIS patient. These differences in underlying mechanisms are a reflection of the variations in symptoms, clinical scores and outcomes reported in literature. More insight in these mechanisms is necessary in order to optimize future diagnostic and treatment strategies for patients with SIS symptoms.</p> <p>Trial registration</p> <p>Dutch Trial Registry (Nederlands Trial Register) <a href="http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2283">NTR2283</a>.</p

Combining femoral and acetabular parameters in femoroacetabular impingement : the omega surface

The concept of femoroacetabular impingement (FAI) proposes the development of hip osteoarthritis through motion-induced damage to the acetabular cartilage and labrum. Thus, dynamic interaction of the proximal femur and acetabulum is the crux of FAI. Several types of FAI can be distinguished, but FAI classification is mostly done with separate parameters for acetabular and femoral morphology on planar images, without direct representation of the femoroacetabular interaction. Five main parameters influence impingement between the proximal femur and the acetabular rim: alpha and center edge angles, acetabular and femoral version, and neck-shaft angle. We attempted to integrate these five parameters in order to reflect their interaction and derive a signal comprehensive parameter, the omega surface, to characterize the severity of FAI. The omega surface is a CT-based delineation of the femoral head surface that represents the area for impingement-free motion. The omega surface is determined with dedicated software (Articulis (TM)) and can be determined for various positions of the hip joint. We determined the omega surface in a pilot study for five different hip morphotypes and found the omega surface was smaller in FAI morphotypes than in a normal hip. Furthermore, the omega surface was smaller in symptomatic versus control subjects with FAI morphotypes. The omega surface may therefore help in improved differentiation between symptomatic and asymptomatic FAI hips